Merger Announced: DAS Health, a Premier Healthcare IT and Business Solutions Provider, is now Owned by Coalesce Capital
In a significant move for the healthcare technology sector, Coalesce Capital, a private equity firm specialising in investments in human capital-driven and technology-enabled services companies, has acquired a majority stake in DAS Health Ventures. The deal, announced publicly in June 2025, marks a strategic growth partnership that positions DAS Health for broader expansion and strengthened service offerings in the healthcare IT market.
Based in Tampa, Florida, DAS Health is a leading provider of healthcare IT and business solutions, founded in 2003. The company offers a comprehensive suite of IT, cybersecurity, revenue cycle management, and business solutions that serve thousands of healthcare organisations across North America. DAS Health's services aim to streamline workflows, increase productivity, and improve patient care.
The acquisition will see Coalesce Capital investing in technology, talent, and strategic acquisitions to further expand DAS Health’s capabilities and market reach. Sheridan Capital Partners, an earlier investor since 2021, will retain a minority stake and continue supporting DAS Health’s growth.
Michelle Jaeger, President and CEO of DAS Health, expressed optimism about this new partnership, highlighting the commitment to enhancing operational efficiency and patient care through innovative solutions. Stephanie Geveda, Founder and Managing Partner at Coalesce Capital, emphasised the critical role DAS Health plays in solving key healthcare challenges related to patient data management, regulatory compliance, and operational demands. She underscored the firm’s excitement to back a company with a proven track record that has already positively impacted over 15 million patients.
Latham & Watkins advised Coalesce Capital on the transaction, confirming the deal's legal structuring was facilitated by experienced counsel. The transaction financial terms were not disclosed.
Houlihan Lokey and McDermott Will & Emery LLP served as advisors to DAS Health and its shareholders. Coalesce Capital, with over $1.4 billion of regulatory assets under management, is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity. The firm partners with companies in the verticals of providers and provider services, healthcare IT and outsourced services, and consumer health and medical products.
With this acquisition, Coalesce Capital and DAS Health are poised to make a substantial impact on the healthcare IT landscape, driving innovation and improving patient care through strategic investments and partnerships.
In this partnership, Coalesce Capital plans to invest in DAS Health's technology, talent, and strategic acquisitions to boost its capabilities and cloud expansion, ensuring compliance with security regulations. The strategic growth move aims to strengthen DAS Health's services in patient data management and improve overall healthcare IT market performance.
